Novel carbapenem-hydrolyzing oxacillinase OXA-62 from Pandoraea pnomenusaSCHNEIDER, Ines; QUEENAN, Anne Marie; BAUERNFEIND, Adolf et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 4, pp 1330-1335, issn 0066-4804, 6 p.Article

Appropriate use of the carbapenemsBRINK, A. J; FELDMAN, C; GROLMAN, D. C et al.SAMJ. South African medical journal. 2004, Vol 94, Num 10, pp 857-861, issn 0256-9574, 5 p., 2Article

Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter spHOSSAIN, Ashfaque; FERRARO, M. J; PINO, R. M et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 11, pp 4438-4440, issn 0066-4804, 3 p.Article

Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing β-lactamaseALBA, Jimena; ISHII, Yoshikazu; THOMSON, Kenneth et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 11, pp 4760-4762, issn 0066-4804, 3 p.Article

In vitro antimicrobial activity of doripenem, a new carbapenemYIGONG GE; WIKLER, Matthew A; SAHM, Daniel F et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 4, pp 1384-1396, issn 0066-4804, 13 p.Article

Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenemBHAVNANI, Sujata M; HAMMEL, Jeffrey P; CIRINCIONE, Brenda B et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 9, pp 3944-3947, issn 0066-4804, 4 p.Article

Ertapenem: a Group 1 carbapenem with distinct antibacterial and pharmacological propertiesHAMMOND, Milton L.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, pp ii7-ii9, issn 0305-7453, SUP2Article

Pharmacokinetics and disposition of CS-023 (RO4908463), a novel parenteral carbapenem, in animalsSHIBAYAMA, Takahiro; MATSUSHITA, Yoko; KAWAI, Kenji et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 1, pp 257-263, issn 0066-4804, 7 p.Article

In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenemKOGA, Tetsufumi; ABE, Tomomi; SHIBAYAMA, Takahiro et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 8, pp 3239-3250, issn 0066-4804, 12 p.Article

Safety and tolerability of ertapenemTEPPLER, Hedy; GESSER, Richard M; FRIEDLAND, Ian R et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, pp ii75-ii81, issn 0305-7453, SUP2Article

Carbapenems: Past, Present, and FuturePAPP-WALLACE, Krisztina M; ENDIMIANI, Andrea; TARACILA, Magdalena A et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 11, pp 4943-4960, issn 0066-4804, 18 p.Article

Susceptibility of naturally occurring carbapenem antibiotics to renal dehydropeptidase-I. An easy assay using a plate technique based on a novel chromogenic β-lactamase substrateSCHINDLER, P; HUBER, G; KONIG, W et al.Journal of antibiotics (Tokyo. 1968). 1983, Vol 36, Num 7, pp 876-879, issn 0021-8820Article

Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene bla_oxn-23 in Acinetobacter bautnanniiCORVEE, Stéphane; POIREL, Laurent; NAAS, Thierry et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 4, pp 1530-1533, issn 0066-4804, 4 p.Article

Intraabdominal tissue concentration of ertapenemWITTAU, M; WAGNER, E; KAEVER, V et al.Journal of antimicrobial chemotherapy (Print). 2006, Vol 57, Num 2, pp 312-316, issn 0305-7453, 5 p.Article

In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolatesWEXLER, Hannah M; ENGEL, Adrian E; GLASS, Daniel et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 10, pp 4413-4417, issn 0066-4804, 5 p.Article

Development of a nanofiltration process to improve the stability of a novel anti-MRSA carbapenem drug candidateANTONUCCI, V; YEN, D; KELLY, J et al.Journal of pharmaceutical sciences. 2002, Vol 91, Num 4, pp 923-932, issn 0022-3549Article

Carbapenems in serious infections : A risk-benefit assessmentNORRBY, S. R.Drug safety. 2000, Vol 22, Num 3, pp 191-194, issn 0114-5916Article

A pheromone-independent CarR protein controls carbapenem antibiotic synthesis in the opportunistic human pathogen Serratia marcescensCOX, A. R. J; THOMSON, N. R; BYCROFT, B et al.Microbiology (Reading). 1998, Vol 144, pp 201-209, issn 1350-0872, 1Article

A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world widePFALLER, M. A; JONES, R. N.Diagnostic microbiology and infectious disease. 1997, Vol 28, Num 4, pp 157-163, issn 0732-8893Article

Stereospecific synthesis of a 1β-methylcarbapenem intermediateODA, K; NISHI, T.Journal of antibiotics (Tokyo. 1968). 1997, Vol 50, Num 5, pp 446-448, issn 0021-8820Article

Pharmacokinetics of meropenem in animals, healthy volunteers, and patientsMOON, Y. S. K; CHUNG, K. C; GILL, M. A et al.Clinical infectious diseases. 1997, Vol 24, pp S249-S255, issn 1058-4838, SUP2Article

Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene bla_OXA-58 in Acinetobacter baumanniiPOIREL, Laurent; NORDMANN, Patrice.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 4, pp 1442-1448, issn 0066-4804, 7 p.Article

Stability and degradation kinetics of meropenem in powder for injection and reconstituted sampleMENDEZ, Andreas S. L; DALOMO, Jean; STEPPE, Martin et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 4, pp 1363-1366, issn 0731-7085, 4 p.Article

Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumanniiHERITIER, Claire; POIREL, Laurent; LAMBERT, Thierry et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 8, pp 3198-3202, issn 0066-4804, 5 p.Article

Effect of ertapenem protein binding on killing of bacteriaNIX, David E; MATTHIAS, Kathryn R; FERGUSON, Emily C et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 9, pp 3419-3424, issn 0066-4804, 6 p.Article